rt-cgm dexcom g5 mobile Search Results


rtcgm  (Dexcom Inc)
86
Dexcom Inc rtcgm
Participant flow diagram of the matched T1D <t>rtCGM</t> switch cohort and <t>T1D</t> <t>isCGM</t> cohort.
Rtcgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/dexcom+g6/pmc12434447-78-14-15
Average 86 stars, based on 1 article reviews
rtcgm - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
periodic rtcgm  (Dexcom Inc)
86
Dexcom Inc periodic rtcgm
Participant flow diagram of the matched T1D <t>rtCGM</t> switch cohort and <t>T1D</t> <t>isCGM</t> cohort.
Periodic Rtcgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/dexcom+g5/pm40757453-87-374-376
Average 86 stars, based on 1 article reviews
periodic rtcgm - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
rt cgm device  (Dexcom Inc)
86
Dexcom Inc rt cgm device
Participant flow diagram of the matched T1D <t>rtCGM</t> switch cohort and <t>T1D</t> <t>isCGM</t> cohort.
Rt Cgm Device, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/cgm+rt/pm38476023-41-6-8
Average 86 stars, based on 1 article reviews
rt cgm device - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
rtcgm dexcom g5  (Dexcom Inc)
86
Dexcom Inc rtcgm dexcom g5
Participant flow diagram of the matched T1D <t>rtCGM</t> switch cohort and <t>T1D</t> <t>isCGM</t> cohort.
Rtcgm Dexcom G5, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/dexcom+g5+rtcgm/pmc12590064-36-26-27
Average 86 stars, based on 1 article reviews
rtcgm dexcom g5 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
real time cgm rtcgm systems systems dexcom g5 and g6  (Dexcom Inc)
86
Dexcom Inc real time cgm rtcgm systems systems dexcom g5 and g6
Participant flow diagram of the matched T1D <t>rtCGM</t> switch cohort and <t>T1D</t> <t>isCGM</t> cohort.
Real Time Cgm Rtcgm Systems Systems Dexcom G5 And G6, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/dexcom+g6+rtcgm+system/pm41865177-35-9-13
Average 86 stars, based on 1 article reviews
real time cgm rtcgm systems systems dexcom g5 and g6 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
g7 rt cgm systems  (Dexcom Inc)
86
Dexcom Inc g7 rt cgm systems
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
G7 Rt Cgm Systems, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/cgm+systems/pmc13012535-117-11-6
Average 86 stars, based on 1 article reviews
g7 rt cgm systems - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
rt cgm data  (Dexcom Inc)
86
Dexcom Inc rt cgm data
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
Rt Cgm Data, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/cgm+data+dexcom+g6/10__1089_slash_dia__2022__2525__abstracts-4059-6-10
Average 86 stars, based on 1 article reviews
rt cgm data - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
rtcgm medtrum touch care nano  (Medtrum Technologies Inc)
90
Medtrum Technologies Inc rtcgm medtrum touch care nano
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
Rtcgm Medtrum Touch Care Nano, supplied by Medtrum Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/touchcare/pm35033598-40-11-12
Average 90 stars, based on 1 article reviews
rtcgm medtrum touch care nano - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
enlite  (Medtronic inc)
90
Medtronic inc enlite
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
Enlite, supplied by Medtronic inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/enlite/10__17925_slash_ee__2018__14__1__24-40-7-9
Average 90 stars, based on 1 article reviews
enlite - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
rtcgm device eversense  (Senseonics)
90
Senseonics rtcgm device eversense
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
Rtcgm Device Eversense, supplied by Senseonics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/rtcgm+device+eversense/pmc08099956-119-16-20
Average 90 stars, based on 1 article reviews
rtcgm device eversense - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
rtcgm sensor eversense  (Senseonics)
90
Senseonics rtcgm sensor eversense
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
Rtcgm Sensor Eversense, supplied by Senseonics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/rtcgm+sensor+eversense/pm30348844-54-14-43
Average 90 stars, based on 1 article reviews
rtcgm sensor eversense - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Participant flow diagram of the matched T1D rtCGM switch cohort and T1D isCGM cohort.

Journal: Diabetic Medicine

Article Title: Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study

doi: 10.1111/dme.70119

Figure Lengend Snippet: Participant flow diagram of the matched T1D rtCGM switch cohort and T1D isCGM cohort.

Article Snippet: Participants were required to have switched from isCGM (FreeStyle Libre or Libre 2) to rtCGM (Dexcom G5 or G6) use between April 1, 2018, and July 31, 2023, and have used each CGM system for at least 3 months.

Techniques:

Net changes in non-insulin medication class count stratified by cohort and RT-CGM use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.

Journal: Diabetes, Metabolic Syndrome and Obesity

Article Title: Impact of Real-Time Continuous Glucose Monitoring on Medication Use and Glycemic Control in Type 2 Diabetes Across Therapy Regimens

doi: 10.2147/DMSO.S574769

Figure Lengend Snippet: Net changes in non-insulin medication class count stratified by cohort and RT-CGM use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.

Article Snippet: The RT-CGM group included individuals initiating Dexcom G4, G5, G6, or G7 RT-CGM systems, identified by National Drug Codes (NDCs; Supplementary Table 1 ), with the index date as the first RT-CGM claim.

Techniques: Medications

Proportion of each cohort achieving A1c targets stratified by RT-CGM use or CGM non-use. ( A ) Proportion of NIT cohort achieving A1c goals at follow-up, ( B ) Proportion of BIT cohort achieving A1c goals at follow-up, ( C ) Proportion of IIT cohort achieving A1c goals at follow-up, ( D and E ) Proportion of each cohort with a baseline A1c above the indicated target meeting the target at follow-up. **, p<0.001; ***, p<0.0001.

Journal: Diabetes, Metabolic Syndrome and Obesity

Article Title: Impact of Real-Time Continuous Glucose Monitoring on Medication Use and Glycemic Control in Type 2 Diabetes Across Therapy Regimens

doi: 10.2147/DMSO.S574769

Figure Lengend Snippet: Proportion of each cohort achieving A1c targets stratified by RT-CGM use or CGM non-use. ( A ) Proportion of NIT cohort achieving A1c goals at follow-up, ( B ) Proportion of BIT cohort achieving A1c goals at follow-up, ( C ) Proportion of IIT cohort achieving A1c goals at follow-up, ( D and E ) Proportion of each cohort with a baseline A1c above the indicated target meeting the target at follow-up. **, p<0.001; ***, p<0.0001.

Article Snippet: The RT-CGM group included individuals initiating Dexcom G4, G5, G6, or G7 RT-CGM systems, identified by National Drug Codes (NDCs; Supplementary Table 1 ), with the index date as the first RT-CGM claim.

Techniques: